In this article we will dive into NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) as a possible candidate for quality investing. Investors should always do their own research, but we noticed NEUROCRINE BIOSCIENCES INC showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.
Looking into the quality metrics of NEUROCRINE BIOSCIENCES INC
The 5-year revenue growth of NEUROCRINE BIOSCIENCES INC has been remarkable, with 33.13% increase. This showcases the company's strong performance in driving revenue growth and indicates its competitiveness within the market.
The ROIC excluding cash and goodwill of NEUROCRINE BIOSCIENCES INC stands at 21.89%, reflecting the company's strong financial management and profitability. This metric underscores its ability to generate favorable returns on the capital invested in its core operations.
NEUROCRINE BIOSCIENCES INC demonstrates a well-balanced Debt/Free Cash Flow Ratio of 0.0, indicating effective debt management and strong cash flow generation. This ratio suggests the company has a sustainable financial position and the capacity to allocate capital efficiently.
NEUROCRINE BIOSCIENCES INC exhibits impressive Profit Quality (5-year) with a 208.0% ratio, reflecting its consistent ability to generate high-quality profits. This metric underscores the company's strong financial performance and commitment to delivering sustainable earnings.
NEUROCRINE BIOSCIENCES INC has experienced impressive EBIT growth over the past 5 years, with 60.65% increase. This reflects the company's effective operational performance and highlights its potential for long-term financial success.
NEUROCRINE BIOSCIENCES INC demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.
What is the full fundamental picture of NASDAQ:NBIX telling us.
ChartMill utilizes a proprietary algorithm to assign a Fundamental Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of fundamental indicators and properties.
NBIX gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 572 industry peers in the Biotechnology industry. NBIX gets an excellent profitability rating and is at the same time showing great financial health properties. NBIX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings could make NBIX a good candidate for value and growth and quality investing.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.